189 related articles for article (PubMed ID: 8005664)
21. Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo Model.
Clarke D; Letendre C; Lecours MP; Lemire P; Galbas T; Thibodeau J; Segura M
J Immunol Res; 2016; 2016():5290604. PubMed ID: 26989699
[TBL] [Abstract][Full Text] [Related]
22. Intracellular and extracellular cytokine production by human mixed mononuclear cells in response to group B streptococci.
Kwak DJ; Augustine NH; Borges WG; Joyner JL; Green WF; Hill HR
Infect Immun; 2000 Jan; 68(1):320-7. PubMed ID: 10603404
[TBL] [Abstract][Full Text] [Related]
23. Isogenic group B streptococci devoid of capsular polysaccharide or beta-hemolysin: pulmonary hemodynamic and gas exchange effects during bacteremia in piglets.
Gibson RL; Redding GJ; Truog WE; Henderson WR; Rubens CE
Pediatr Res; 1989 Sep; 26(3):241-5. PubMed ID: 2685736
[TBL] [Abstract][Full Text] [Related]
24. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.
Rubens CE; Wessels MR; Heggen LM; Kasper DL
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7208-12. PubMed ID: 2823254
[TBL] [Abstract][Full Text] [Related]
25. Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci.
Mikamo H; Johri AK; Paoletti LC; Madoff LC; Onderdonk AB
Infect Immun; 2004 Aug; 72(8):4716-22. PubMed ID: 15271933
[TBL] [Abstract][Full Text] [Related]
26. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
[TBL] [Abstract][Full Text] [Related]
27. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).
von Hunolstein C; D'Ascenzi S; Wagner B; Jelínková J; Alfarone G; Recchia S; Wagner M; Orefici G
Infect Immun; 1993 Apr; 61(4):1272-80. PubMed ID: 8454331
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of virulence by group B streptococcal polysaccharides.
Levy NJ; Nicholson-Weller A; Baker CJ; Kasper DL
J Infect Dis; 1984 Jun; 149(6):851-60. PubMed ID: 6376652
[TBL] [Abstract][Full Text] [Related]
29. Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release.
Levy O; Jean-Jacques RM; Cywes C; Sisson RB; Zarember KA; Godowski PJ; Christianson JL; Guttormsen HK; Carroll MC; Nicholson-Weller A; Wessels MR
Infect Immun; 2003 Nov; 71(11):6344-53. PubMed ID: 14573654
[TBL] [Abstract][Full Text] [Related]
30. Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion.
Gibson RL; Lee MK; Soderland C; Chi EY; Rubens CE
Infect Immun; 1993 Feb; 61(2):478-85. PubMed ID: 8423076
[TBL] [Abstract][Full Text] [Related]
31. Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.
Marques MB; Kasper DL; Shroff A; Michon F; Jennings HJ; Wessels MR
Infect Immun; 1994 May; 62(5):1593-9. PubMed ID: 8168919
[TBL] [Abstract][Full Text] [Related]
32. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci.
Mancuso G; Cusumano V; Genovese F; Gambuzza M; Beninati C; Teti G
Infect Immun; 1997 Sep; 65(9):3731-5. PubMed ID: 9284145
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
Cusumano V; Genovese F; Mancuso G; Carbone M; Fera MT; Teti G
Infect Immun; 1996 Jul; 64(7):2850-2. PubMed ID: 8698523
[TBL] [Abstract][Full Text] [Related]
34. Effects of fibronectin and group B streptococci on tumour necrosis factor-alpha production by human culture-derived macrophages.
Peat EB; Augustine NH; Drummond WK; Bohnsack JF; Hill HR
Immunology; 1995 Mar; 84(3):440-5. PubMed ID: 7751028
[TBL] [Abstract][Full Text] [Related]
35. Capsular polysaccharide of Streptococcus agalactiae is an essential virulence factor for infection in Nile tilapia (Oreochromis niloticus Linn.).
Zhang D; Ke X; Liu Z; Cao J; Su Y; Lu M; Gao F; Wang M; Yi M; Qin F
J Fish Dis; 2019 Feb; 42(2):293-302. PubMed ID: 30549284
[TBL] [Abstract][Full Text] [Related]
36. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
Segura M
Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
[TBL] [Abstract][Full Text] [Related]
37. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
[TBL] [Abstract][Full Text] [Related]
38. Group B streptococci. Role of capsular polysaccharide on virulence and induction of septic arthritis.
Tissi L; von Hunolstein C; Parisi L; Bistoni F; Orefici G
Adv Exp Med Biol; 1997; 418():817-8. PubMed ID: 9331777
[No Abstract] [Full Text] [Related]
39. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci.
Henneke P; Takeuchi O; van Strijp JA; Guttormsen HK; Smith JA; Schromm AB; Espevik TA; Akira S; Nizet V; Kasper DL; Golenbock DT
J Immunol; 2001 Dec; 167(12):7069-76. PubMed ID: 11739528
[TBL] [Abstract][Full Text] [Related]
40. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.
Wessels MR; Rubens CE; Benedí VJ; Kasper DL
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8983-7. PubMed ID: 2554337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
